Erratum: Therapeutic assessment of combination therapy with a neprilysin inhibitor and angiotensin type 1 receptor antagonist on angiotensin II - Induced atherosclerosis, abdominal aortic aneurysms, and hypertensin (J Pharmacol Exp Ther (2021) 377 (326-335) DOI: 10.1124/jpet.121.000525)

Y. Alsiraj; S. E. Thatcher; C. L. Liang; H. Ali; M. Ensor; L. A. Cassis

doi:10.1124/jpet.121.000525err

Erratum: Therapeutic assessment of combination therapy with a neprilysin inhibitor and angiotensin type 1 receptor antagonist on angiotensin II - Induced atherosclerosis, abdominal aortic aneurysms, and hypertensin (J Pharmacol Exp Ther (2021) 377 (326-335) DOI: 10.1124/jpet.121.000525)

Y. Alsiraj, S. E. Thatcher, C. L. Liang, H. Ali, M. Ensor, L. A. Cassis

Research output: Contribution to journal › Comment/debate

Abstract

The PDF and HTML versions of the article have been corrected. The compositor apologizes for any inconvenience caused by these errors.

Original language	English
Pages (from-to)	322
Number of pages	1
Journal	Journal of Pharmacology and Experimental Therapeutics
Volume	378
Issue number	3
DOIs	https://doi.org/10.1124/jpet.121.000525err
State	Published - Sep 1 2021

Bibliographical note

Publisher Copyright:
© 2021 American Society for Pharmacology and Experimental Therapy. All rights reserved.

ASJC Scopus subject areas

Molecular Medicine
Pharmacology

Access to Document

10.1124/jpet.121.000525err

Fingerprint

Dive into the research topics of 'Erratum: Therapeutic assessment of combination therapy with a neprilysin inhibitor and angiotensin type 1 receptor antagonist on angiotensin II - Induced atherosclerosis, abdominal aortic aneurysms, and hypertensin (J Pharmacol Exp Ther (2021) 377 (326-335) DOI: 10.1124/jpet.121.000525)'. Together they form a unique fingerprint.

Cite this

Alsiraj, Y., Thatcher, S. E., Liang, C. L., Ali, H., Ensor, M., & Cassis, L. A. (2021). Erratum: Therapeutic assessment of combination therapy with a neprilysin inhibitor and angiotensin type 1 receptor antagonist on angiotensin II - Induced atherosclerosis, abdominal aortic aneurysms, and hypertensin (J Pharmacol Exp Ther (2021) 377 (326-335) DOI: 10.1124/jpet.121.000525). Journal of Pharmacology and Experimental Therapeutics, 378(3), 322. https://doi.org/10.1124/jpet.121.000525err

Alsiraj, Y. ; Thatcher, S. E. ; Liang, C. L. et al. / Erratum : Therapeutic assessment of combination therapy with a neprilysin inhibitor and angiotensin type 1 receptor antagonist on angiotensin II - Induced atherosclerosis, abdominal aortic aneurysms, and hypertensin (J Pharmacol Exp Ther (2021) 377 (326-335) DOI: 10.1124/jpet.121.000525). In: Journal of Pharmacology and Experimental Therapeutics. 2021 ; Vol. 378, No. 3. pp. 322.

@article{a450a35a6c61490aafae2326efd676a9,

title = "Erratum: Therapeutic assessment of combination therapy with a neprilysin inhibitor and angiotensin type 1 receptor antagonist on angiotensin II - Induced atherosclerosis, abdominal aortic aneurysms, and hypertensin (J Pharmacol Exp Ther (2021) 377 (326-335) DOI: 10.1124/jpet.121.000525)",

abstract = "The PDF and HTML versions of the article have been corrected. The compositor apologizes for any inconvenience caused by these errors.",

author = "Y. Alsiraj and Thatcher, {S. E.} and Liang, {C. L.} and H. Ali and M. Ensor and Cassis, {L. A.}",

year = "2021",

month = sep,

day = "1",

doi = "10.1124/jpet.121.000525err",

language = "English",

volume = "378",

pages = "322",

number = "3",

}

Alsiraj, Y, Thatcher, SE, Liang, CL, Ali, H, Ensor, M & Cassis, LA 2021, 'Erratum: Therapeutic assessment of combination therapy with a neprilysin inhibitor and angiotensin type 1 receptor antagonist on angiotensin II - Induced atherosclerosis, abdominal aortic aneurysms, and hypertensin (J Pharmacol Exp Ther (2021) 377 (326-335) DOI: 10.1124/jpet.121.000525)', Journal of Pharmacology and Experimental Therapeutics, vol. 378, no. 3, pp. 322. https://doi.org/10.1124/jpet.121.000525err

Erratum: Therapeutic assessment of combination therapy with a neprilysin inhibitor and angiotensin type 1 receptor antagonist on angiotensin II - Induced atherosclerosis, abdominal aortic aneurysms, and hypertensin (J Pharmacol Exp Ther (2021) 377 (326-335) DOI: 10.1124/jpet.121.000525). / Alsiraj, Y.; Thatcher, S. E.; Liang, C. L. et al.
In: Journal of Pharmacology and Experimental Therapeutics, Vol. 378, No. 3, 01.09.2021, p. 322.

Research output: Contribution to journal › Comment/debate

TY - JOUR

T1 - Erratum

T2 - Therapeutic assessment of combination therapy with a neprilysin inhibitor and angiotensin type 1 receptor antagonist on angiotensin II - Induced atherosclerosis, abdominal aortic aneurysms, and hypertensin (J Pharmacol Exp Ther (2021) 377 (326-335) DOI: 10.1124/jpet.121.000525)

AU - Alsiraj, Y.

AU - Thatcher, S. E.

AU - Liang, C. L.

AU - Ali, H.

AU - Ensor, M.

AU - Cassis, L. A.

PY - 2021/9/1

Y1 - 2021/9/1

N2 - The PDF and HTML versions of the article have been corrected. The compositor apologizes for any inconvenience caused by these errors.

AB - The PDF and HTML versions of the article have been corrected. The compositor apologizes for any inconvenience caused by these errors.

UR - http://www.scopus.com/inward/record.url?scp=85116996242&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85116996242&partnerID=8YFLogxK

U2 - 10.1124/jpet.121.000525err

DO - 10.1124/jpet.121.000525err

M3 - Comment/debate

C2 - 34561274

AN - SCOPUS:85116996242

SN - 0022-3565

VL - 378

SP - 322

JO - Journal of Pharmacology and Experimental Therapeutics

JF - Journal of Pharmacology and Experimental Therapeutics

IS - 3

ER -

Alsiraj Y, Thatcher SE, Liang CL, Ali H, Ensor M, Cassis LA. Erratum: Therapeutic assessment of combination therapy with a neprilysin inhibitor and angiotensin type 1 receptor antagonist on angiotensin II - Induced atherosclerosis, abdominal aortic aneurysms, and hypertensin (J Pharmacol Exp Ther (2021) 377 (326-335) DOI: 10.1124/jpet.121.000525). Journal of Pharmacology and Experimental Therapeutics. 2021 Sep 1;378(3):322. doi: 10.1124/jpet.121.000525err

Erratum: Therapeutic assessment of combination therapy with a neprilysin inhibitor and angiotensin type 1 receptor antagonist on angiotensin II - Induced atherosclerosis, abdominal aortic aneurysms, and hypertensin (J Pharmacol Exp Ther (2021) 377 (326-335) DOI: 10.1124/jpet.121.000525)

Abstract

Bibliographical note

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this